YOLFTbeta
68

Chison Medical Technologies Co Ltd

688358 · SHG · Healthcare / Medical Devices

26.33CNY-0.33 (-1.24%)

Price History

Full chart

Market Stats

Previous Close26.66
Open26.66
Day Range26.01 – 26.94
52-Week Range25.03 – 44.78
Volume708.87K
Market Cap3.25B
P/E (TTM)27.84
Forward P/E0.00
EPS1.04
Dividend Yield6.49%
Beta0.39
50-Day Avg28.30
200-Day Avg31.48

About

Chison Medical Technologies Co., Ltd. develops, manufactures, and sells diagnostic ultrasound systems in China and internationally. Its products include cart-based, portable, handheld, and B&W ultrasound systems for radiology, cardiovascular, women's health, general imaging, POC, and primary care applications. SonoAI. The company was founded in 1996 and is based in Wuxi, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Ruoli Mo
  • Employees478
  • HeadquartersNo.3, Changjiang South Road, Wuxi, China, 214028, China
  • Websitehttps://www.chison.com

Leadership

  • Ms. Ruoli MoGM & Chairman · b. 1974
  • Mr. Feng ZhouDeputy GM, Secretary, CFO, Accounting Supervisor & Director · b. 1977
  • Mr. Wang HongChief Technology Officer · b. 1964
  • Mr. Xiaoming ZhuInnovation Center Director · b. 1982
  • Mr. Zhang YongSupervisor & Director of R & D Center High-End Color Doppler Ultrasound · b. 1984

Financials

Income Statement

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue166.95M271.62M326.97M369.76M333.09M397.81M380.84M483.84M468.70M447.35M
Growth (%)-+62.70%+20.37%+13.09%-9.92%+19.43%-4.27%+27.04%-3.13%-4.55%
Cost of Revenue72.28M111.80M129.86M146.29M139.21M178.89M160.60M208.34M196.94M178.25M
Gross Profit94.67M159.83M197.11M223.47M193.88M218.92M220.24M275.50M271.75M447.35M
Gross Margin56.70%58.84%60.28%60.44%58.21%55.03%57.83%56.94%57.98%100.00%
Operating Expense68.26M88.50M90.39M107.49M85.10M93.90M105.11M113.28M114.45M319.86M
Operating Income26.41M71.33M106.71M115.98M108.78M125.03M115.13M162.22M157.30M127.49M
Operating Margin15.82%26.26%32.64%31.37%32.66%31.43%30.23%33.53%33.56%28.50%
EBITDA38.08M78.67M112.99M124.57M119.70M133.83M127.20M174.60M168.84M140.45M
EBITDA Margin22.81%28.96%34.56%33.69%35.94%33.64%33.40%36.09%36.02%31.40%
Net Income30.47M64.04M95.06M105.13M99.64M112.47M105.84M146.48M140.51M116.63M
Net Income Margin18.25%23.58%29.07%28.43%29.91%28.27%27.79%30.27%29.98%26.07%
R&D28.27M33.12M41.35M52.02M55.64M72.29M77.88M77.07M79.63M74.49M
R&D as % of Total Revenue16.93%12.19%12.65%14.07%16.70%18.17%20.45%15.93%16.99%16.65%
Interest Expense0017.56K506.92K1.21M2.42M2.33M748.03K734.63K309.91K
Interest Expense % of Total Revenue0.00%0.00%0.01%0.14%0.36%0.61%0.61%0.15%0.16%0.07%

Balance Sheet

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets153.04M237.79M323.50M1.29B1.35B1.40B1.51B1.52B1.60B1.59B
Total Liabilities76.72M93.61M114.33M119.71M156.70M152.49M200.42M153.42M176.42M211.43M
Total Equity76.32M144.18M209.17M1.17B1.19B1.25B1.31B1.37B1.42B1.38B
Cash53.45M84.35M135.31M1.06B302.05M445.87M446.20M688.77M985.62M1.01B
Total Debt----1.76M1.37M6.11M10.34M2.67M-
Net Debt-53.45M-84.35M-135.31M-1.06B-300.29M-444.50M-440.09M-678.43M-982.95M-

Cash Flow

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow42.15M62.20M71.42M79.83M82.45M39.96M63.74M85.91M140.68M107.17M
Investing Cash Flow-7.46M-14.19M-5.77M-5.34M-748.61M164.09M-45.43M-241.18M555.53M-
Financing Cash Flow-30.00M-13.06M-18.95M849.23M-91.18M-64.61M-38.91M-89.53M-93.80M-
Capital Expenditure7.46M14.19M5.77M7.79M30.88M39.19M52.21M34.01M8.85M14.41M
Free Cash Flow34.69M48.01M65.65M72.03M51.56M775.57K11.53M51.90M131.83M92.76M
Dividends Paid30.00M13.06M18.95M63.00M80.00M64.00M40.00M78.49M89.50M111.87M
FCF to OCF82.31%77.19%91.92%90.24%62.54%1.94%18.09%60.41%93.71%86.56%
Dividend Paid to FCF86.47%27.20%28.87%87.46%155.15%8252.03%346.86%151.23%67.89%120.61%

Earnings

Report DateDec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate--------------
EPS Actual0.390.160.190.240.300.200.220.270.310.220.450.44-0.180.47
Surprise--------------
Timing--------------

Key Statistics & Ratios

Market Cap3.25B
Enterprise Value2.26B
Trailing P/E27.84
Forward P/E0.00
Price / Sales7.36
Price / Book2.41
EPS1.04
Book Value12.20
Revenue (TTM)441.10M
Gross Profit (TTM)255.53M
EBITDA93.55M
Profit Margin26.24%
Operating Margin8.39%
Return on Equity8.43%
Return on Assets3.24%
Shares Outstanding112.13M
Shares Float31.87M
Beta0.39
Dividend Yield6.49%
Dividend Rate1.88
Payout Ratio125.00%

Dividends

20231×
0.70Jul 14, 2023
20221×
0.50Jul 7, 2022
20211×
0.57Jul 15, 2021
20201×
0.71Jun 17, 2020

Stock Splits

  • Jul 7, 20227:5